Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001412097 | SCV001614173 | likely benign | Myofibrillar myopathy 6; Dilated cardiomyopathy 1HH | 2023-10-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004038087 | SCV005021591 | likely benign | Cardiovascular phenotype | 2023-10-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001529803 | SCV005051153 | likely benign | not provided | 2024-05-01 | criteria provided, single submitter | clinical testing | BAG3: BP4, BP7 |
Breakthrough Genomics, |
RCV001529803 | SCV005220224 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Diagnostic Laboratory, |
RCV001529803 | SCV001743898 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV001699541 | SCV001917917 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001529803 | SCV001932639 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001529803 | SCV001951162 | likely benign | not provided | no assertion criteria provided | clinical testing |